Literature DB >> 19656266

Salivary profile and oxidative stress in children and adolescents with cystic fibrosis.

G Livnat1, L Bentur, E Kuzmisnsky, R M Nagler.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is characterized by altered exocrine secretions; however, no comprehensive compositional profile of CF serous and mucous saliva secretions has been published.
DESIGN: We analyzed salivary flow rate and composition, and oxidative stress-related parameters, comparing CF patients with non-CF bronchiectasis patients and the healthy controls.
RESULTS: Median salivary magnesium concentration and lactate dehydrogenase activity were significantly lower in CF patients than in the healthy controls. Salivary total protein concentration was 45% higher in CF patients than in non-CF bronchiectasis patients. CF patients showed 8% lower levels of peroxidase compared with non-CF bronchiectasis. Salivary total antioxidant status, superoxide dismutase and uric acid values in the CF group were higher by 15%, 35% and 31%, respectively, than in both control groups.
CONCLUSIONS: Cystic fibrosis patients demonstrated altered salivary profile, especially in antioxidant enzymatic and molecular activity, possibly resulting from the oral cavity's ongoing inflammatory and oxidative process. Free radical mechanisms may be involved in CF pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656266     DOI: 10.1111/j.1600-0714.2009.00813.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  10 in total

1.  Localization of cystic fibrosis transmembrane conductance regulator signaling complexes in human salivary gland striated duct cells.

Authors:  Vina Z Zinn; Aditi Khatri; Maija I Mednieks; Arthur R Hand
Journal:  Eur J Oral Sci       Date:  2015-04-22       Impact factor: 2.612

Review 2.  Saliva as a diagnostic tool for oral and systemic diseases.

Authors:  Mohammad A Javaid; Ahad S Ahmed; Robert Durand; Simon D Tran
Journal:  J Oral Biol Craniofac Res       Date:  2015-09-09

Review 3.  Saliva diagnostics - Current views and directions.

Authors:  Karolina Elżbieta Kaczor-Urbanowicz; Carmen Martin Carreras-Presas; Katri Aro; Michael Tu; Franklin Garcia-Godoy; David Tw Wong
Journal:  Exp Biol Med (Maywood)       Date:  2016-12-08

Review 4.  Salivary gland function, development, and regeneration.

Authors:  Alejandro M Chibly; Marit H Aure; Vaishali N Patel; Matthew P Hoffman
Journal:  Physiol Rev       Date:  2022-03-28       Impact factor: 46.500

Review 5.  Salivary and Urinary Total Antioxidant Capacity as Biomarkers of Oxidative Stress in Humans.

Authors:  Ilaria Peluso; Anna Raguzzini
Journal:  Patholog Res Int       Date:  2016-02-07

6.  Salivary Biomarkers and Oral Microbial Load in Relation to the Dental Status of Adults with Cystic Fibrosis.

Authors:  Tamara Pawlaczyk-Kamieńska; Maria Borysewicz-Lewicka; Halina Batura-Gabryel
Journal:  Microorganisms       Date:  2019-12-13

Review 7.  Role of Salivary Biomarkers in Cystic Fibrosis: A Systematic Review.

Authors:  Asma Almeslet; Sarah Alnamlah; Latifa Alanzan; Rawan Aldriwesh; Sha'eah AlWehaiby
Journal:  Biomed Res Int       Date:  2022-01-19       Impact factor: 3.411

8.  Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis.

Authors:  Shuai Nie; Huaibin Zhang; Kathryn M Mayer; Frank G Oppenheim; Frédéric F Little; Jonathan Greenberg; Ahmet Z Uluer; David R Walt
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

Review 9.  Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis.

Authors:  Giulio Cabrini; Alessandro Rimessi; Monica Borgatti; Ilaria Lampronti; Alessia Finotti; Paolo Pinton; Roberto Gambari
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

10.  Estimation of Proinflammatory Factors in the Saliva of Adult Patients with Cystic Fibrosis and Dental Caries.

Authors:  Tomasz Hildebrandt; Anna Zawilska; Agata Trzcionka; Marta Tanasiewicz; Henryk Mazurek; Elżbieta Świętochowska
Journal:  Medicina (Kaunas)       Date:  2020-11-14       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.